Daniel S. Lynch M.B.A.
Executive Chairman,Nimbus Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 81 board members in 8 different organizations across 14 different industries.|
See Board Relationships
Mr. Daniel S. Lynch, also known as Dan, M.B.A., has been the President and Chief Executive Officer at IVREA Pharmaceuticals Inc. since February 1, 2007. Mr. Lynch has been a Venture Partner at Third Rock Ventures, LLC since May 14, 2013. He supports the commercial and business development of existing portfolio companies and serves as a strategic advisor across the portfolio. He has been Executive Chairman at Nimbus Discovery, LLC(Nimbus Therapeutics, Inc.) since November ...
25 First StreetPhone: 617-588-2655
Cambridge, Massachusetts 02141
Board Members Memberships*
Chief Executive Officer, President and Director
Director, Member of Audit Committee and Director of US Oncology Inc
Colgate W. Darden Graduate School of Business Administration
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.